ECD protein is overexpressed in a significant subset of breast cancers and is also upregulated in other cancers (38, –, 41), and its overexpression correlates with poor prognosis and short survival in ErbB2-overexpressing breast cancers (39). Here, ERBB2 is linked to breast cancer.